TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Mid-Size Pharmaceutical – By Type
1.3.2 APAC Mid-Size Pharmaceutical – By Drug Development Type
1.3.3 APAC Mid-Size Pharmaceutical – By Formulation
1.3.4 APAC Mid-Size Pharmaceutical – By Therapy Area
1.3.5 APAC Mid-Size Pharmaceutical – By Country
2. Mid-Size Pharmaceutical– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Mid-Size Pharmaceutical – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Expert Opinion
5. Mid-Size Pharmaceutical Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Disorders
5.1.2 Increasing Product Approval and Launches
5.2 Market Restraints
5.2.1 High Competition Among Market Players
5.3 Market Opportunities
5.3.1 Rising Number of Healthcare Start-ups
5.4 Future Trends
5.4.1 Increasing Focus on R&D
5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market– APAC Analysis
6.1 APAC Mid-Size Pharmaceutical Market Revenue Forecast And Analysis
7. APAC Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type
7.1 Overview
7.2 APAC Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
7.3 Prescription
7.3.1 Overview
7.3.2 Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Over-the-Counter (OTC)
7.4.1 Overview
7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8. APAC Mid-Size Pharmaceutical Market Analysis – By Drug Development Type
8.1 Overview
8.2 APAC Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
8.3 In-House
8.3.1 Overview
8.3.2 In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Outsource
8.4.1 Overview
8.4.2 Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9. APAC Mid-Size Pharmaceutical Market – By Formulation
9.1 Overview
9.2 APAC Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
9.3 Tablets and Capsules
9.3.1 Overview
9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Injectables
9.4.1 Overview
9.4.2 Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Sprays
9.5.1 Overview
9.5.2 Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Other Formulations
9.6.1 Overview
9.6.2 Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10. APAC Mid-Size Pharmaceutical Market – By Therapy Class
10.1 Overview
10.2 APAC Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
10.3 Cardiovascular Diseases
10.3.1 Overview
10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Pain Management
10.4.1 Overview
10.4.2 Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Diabetes
10.5.1 Overview
10.5.2 Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Cancer
10.6.1 Overview
10.6.2 Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Other Diseases
10.7.1 Overview
10.7.2 Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11. APAC Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Overview
11.1.1 APAC: Mid-Size Pharmaceutical Market, by Country, 2022 & 2028 (%)
11.1.1.1 China: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 China: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.2 China: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)
11.1.1.1.3 China: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)
11.1.1.1.4 China: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.1.1.1.5 China: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.1.1.2 Japan: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 Japan: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.2 Japan: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)
11.1.1.2.3 Japan: Mid-Size Pharmaceutical Market, By Drug Development Type , 2019–2028 (USD Million)
11.1.1.2.4 Japan: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.1.1.2.5 Japan: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.1.1.3 India: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 India: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.2 India: Mid-Size Pharmaceutical Market, By Type , 2019–2028 (USD Million)
11.1.1.3.3 India: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)
11.1.1.3.4 India: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.1.1.3.5 India: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.1.1.4 Australia: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.1 Australia: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.2 Australia: Mid-Size Pharmaceutical Market , By Type , 2019–2028 (USD Million)
11.1.1.4.3 Australia: Mid-Size Pharmaceutical Market , By Drug Development Type , 2019–2028 (USD Million)
11.1.1.4.4 Australia: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.1.1.4.5 Australia: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.1.1.5 South Korea: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.5.1 South Korea: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.5.2 South Korea: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)
11.1.1.5.3 South Korea: Mid-Size Pharmaceutical Market, By Drug Development Type , 2019–2028 (USD Million)
11.1.1.5.4 South Korea: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.1.1.5.5 South Korea: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.1.1.6 Rest of APAC: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.6.1 Rest of APAC: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.6.2 Rest of APAC: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)
11.1.1.6.3 Rest of APAC: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)
11.1.1.6.4 Rest of APAC: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.1.1.6.5 Rest of APAC: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
12. Mid-Size Pharmaceutical Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 DAIICHI SANKYO COMPANY LIMITED
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Eisai Co., Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bausch Health Companies Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Regeneron Pharmaceuticals, Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sun Pharmaceutical Industries Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Alexion Pharmaceuticals, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mallinckrodt
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Endo Pharmaceuticals Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. China: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 2. China: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and forecast to 2028 (USD Million)
Table 3. China: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Mid-Size Pharmaceutical Market , By Therapy Area– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Mid-Size Pharmaceutical Market , By Therapy Area– Revenue and Forecast to 2028 (USD Million)
Table 9. India: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 10. India: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)
Table 11. India: Mid-Size Pharmaceutical Market, By Formulation - Revenue and Forecast to 2028 (USD Million)
Table 12. India: Mid-Size Pharmaceutical Market, By Therapy Area– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Mid-Size Pharmaceutical Market , By Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Australia: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Australia: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)
Table 16. Australia: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of APAC: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of APAC: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of APAC: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of APAC: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done By Companies
Table 27. Glossary of Terms